The U.S. bacterial conjunctivitis drugs market driven by such factors are rising incidence of ophthalmic bacterial infection and susceptibility among various age groups ranging from neonates to geriatrics. Additionally, the rising focus of the major players on the production and designing of combination drugs is expected to accelerate the growth of the overall market during the forecast period.
5 months ago